Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stevanato Group S.p.A (STVN) Raw Materials (2020 - 2025)

Stevanato Group S.p.A (STVN) reported Raw Materials of $161.3 million for Q4 2025, up 30.57% year-over-year from $123.5 million in Q4 2024, and up 30.57% on a QoQ basis from $123.5 million in Q4 2024.

Stevanato Group S.p.A (STVN) has 6 years of Raw Materials data on file, last reported at $161.3 million in Q4 2025.

  • Quarterly Raw Materials rose 30.57% year-over-year to $161.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $161.3 million (up 30.57% YoY) and the FY2025 annual result came in at $161.3 million, up 30.57% from the prior year.
  • Raw Materials advanced to $161.3 million in Q4 2025 per STVN's latest filing, from $123.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $161.3 million in Q4 2025 and bottomed at $66.9 million in Q4 2021.
  • The 5-year median for Raw Materials is $123.5 million (2024), against an average of $118.3 million.
  • The widest annual swing landed in 2022, when Raw Materials surged 62.04%; it then retreated 5.95% in 2024.
  • Tracing STVN's Raw Materials over 5 years: stood at $66.9 million in 2021, then jumped by 62.04% to $108.4 million in 2022, then rose by 21.16% to $131.4 million in 2023, then fell by 5.95% to $123.5 million in 2024, then soared by 30.57% to $161.3 million in 2025.
  • Per Business Quant, the three latest STVN Raw Materials figures stand at $161.3 million (Q4 2025), $123.5 million (Q4 2024), and $131.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 161.30 Mn
Dec 31, 2024 123.53 Mn
Dec 31, 2023 131.35 Mn
Dec 31, 2022 108.41 Mn
Dec 31, 2021 66.90 Mn
Dec 31, 2020 49.94 Mn